Cas No.: | 1918143-53-9 |
Chemical Name: | 4-[(2R,4R)-4-({[1-(2,2-difluoro-1,3-benzodioxol-5-yl)cyclopropyl]carbonyl}amino)-7-(difluoromethoxy)-3,4-dihydro-2H-chromen-2-yl]benzoic acid |
Synonyms: | ABBV-2222;ABBV2222;GLPG2222 |
SMILES: | C(O)(=O)C1=CC=C([C@H]2OC3=C(C=CC(OC(F)F)=C3)[C@@H](NC(C(C3=CC=C4OC(F)(F)OC4=C3)3CC3)=O)C2)C=C1 |
Formula: | C28H21F4NO7 |
M.Wt: | 559.47 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | GLPG-2222 (ABBV-2222, Galicaftor) is a novel potent and efficacious CFTR corrector with EC50 of 5 nM; is highly potent (5 nM) and efficacious in cells from multiple CF patient donors that have F508del homozygous mutation; shows potential in clinical trials in patients harboring the F508del CFTR mutation on at least one allele. |